Biofield Corp. (BZET)'s 51% Owned Subsidiary Agrees to Deal Appointing McKinley Infocapital as Korean Exclusive Distributor of Breast Cancer Diagnostic System; Contract has Potential Value of up to $15.3 Million
4/8/2011 8:58:31 AM
More...
|
MacKay Life Sciences, Inc. (Formerly Biofield Corp. (BZET)) to Re-Acquire Control of Its Master License; Signs Agreement to Acquire Majority Interest In MacKay Innotech LTD, Present Holder of the Master License
7/1/2009 9:44:03 AM
More...
|
Biofield Corp. (BZET) Strengthens Balance Sheet through Equity Investment and Debt Conversion
3/5/2009 1:16:05 PM
More...
|
Biofield Corp. (BZET) Expands Arsenal Of Non-Invasive Diagnostic Devices
2/4/2009 8:20:29 AM
More...
|
ValiRx Plc Secures Global Distribution Agreement for Diagnostic Subsidiary ValiBio with Biofield Corp. (BZET); Secures E600,000 from Sale of 10% in Subsidiary
12/15/2008 7:03:54 AM
More...
|
Biofield Corp. (BZET) in $365 Million China Breast Cancer Diagnostic JV
7/2/2008 2:36:37 PM
More...
|
Biofield Corp. (BZET) Releases Details About the National Healthcare Network Which Will Provide Biofield Corp. (BZET)’s and Other Technology in China
6/25/2008 11:04:25 AM
More...
|
Biofield Corp. (BZET) Release: World Renown Biotech Expert & Entrepreneur Appointed New Biofield Chairman
6/23/2008 11:18:46 AM
More...
|
Biofield Corp. (BZET)'s Reverse Stock Split and Uplist Off the Pink Sheets to the OTCBB Approved Effective June 20
6/20/2008 10:25:23 AM
More...
|
Biofield Corp. (BZET)'s Master Licensee to Consummate CareLife China Joint Ventures at Signing Ceremony on June 16
6/4/2008 8:26:50 AM
More...
|
|